Guarino A M, Anderson J B, Pritchard J B, Rall D P
J Toxicol Environ Health. 1976 Sep;2(1):13-24. doi: 10.1080/15287397609529413.
[14C] Methyl mercury was administered by three different routes: intravascular (iv) injection, ingestion, and absorption from the ambient water. After iv administration (0.1 mg/kg) [14C] methyl mercury was rapidly removed from the plasma, followed by slow loss from the hepatopancreas and a strikingly persistent increase in the amount of radioactivity in the tail muscle. Most (80-90%) of the radioactivity in the hepatopancreas was shown by TLC methods to be the parent compound, and approximately 10% of this persisted for 6 days after injection. The half-life in this organ was found to be 21 days. One month after iv treatment with methyl mercury, the only organs that contained more than 0.1 ppm of this xenobiotic were egg masses, male gonads, heart, brain, intestine, and tail muscle. The half-lives for disappearance from sexual organs were greater than 1 month. After ingestion of [14C] methyl mercury (0.1 mg/kg) in food the hepatopancreas contained most of the administered dose at 6 days (68%), while the stomach (10%), tail muscle (8%), and carcass (15%) contained less. A unique distribution pattern emerged 6 days after exposure to [14C] methyl mercury-containing ambient water (0.1 ppm). The tail muscle contained most (50%) of the absorbed dose, whereas the hepatopancreas and carcass contained only 23 and 10%, respectively. In view of the small molecular size and high lipid solubility of methyl mercury and the lipophilic properties of the chitin-protein exoskeleton of the lobster, it is likely that significant uptake directly from the water as well as storage of absorbed methyl mercury occurred in the tail region. Residue analysis on untreated lobsters indicated that the egg masses contained the largest amount of methyl mercury (0.1 ppm). The hepatopancreas and carcass (muscle) levels were less than 0.05 ppm.
[14C]甲基汞通过三种不同途径给予:血管内(静脉)注射、摄入以及从周围水体吸收。静脉注射(0.1毫克/千克)[14C]甲基汞后,血浆中的甲基汞迅速清除,随后肝胰腺中的甲基汞缓慢减少,而尾肌中的放射性则显著持续增加。通过薄层层析法显示,肝胰腺中大部分(80 - 90%)的放射性为母体化合物,注射后约10%的该化合物在6天内持续存在。该器官中的半衰期为21天。用甲基汞进行静脉治疗一个月后,含有超过0.1 ppm这种外源性物质的唯一器官是卵块、雄性性腺、心脏、大脑、肠道和尾肌。性器官中甲基汞消失的半衰期超过1个月。在食物中摄入[14C]甲基汞(0.1毫克/千克)后,6天时肝胰腺中含有大部分给药剂量(68%),而胃(10%)、尾肌(8%)和躯体(15%)中的含量较少。暴露于含[14C]甲基汞的周围水体(0.1 ppm)6天后出现了独特的分布模式。尾肌含有大部分(50%)吸收剂量,而肝胰腺和躯体分别仅含23%和10%。鉴于甲基汞分子尺寸小、脂溶性高以及龙虾几丁质 - 蛋白质外骨骼的亲脂特性,很可能在尾区域直接从水中大量摄取以及储存吸收的甲基汞。对未处理龙虾的残留分析表明,卵块中甲基汞含量最高(0.1 ppm)。肝胰腺和躯体(肌肉)中的含量低于0.05 ppm。